Cargando…
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records
BACKGROUND: In the UK, the cancer antigen 125 (CA125) test is recommended as a first-line investigation in women with symptoms of possible ovarian cancer. AIM: To compare time between initial primary care CA125 test and diagnosis, tumour morphology, and stage in women with normal (<35 U/ml) and a...
Autores principales: | Funston, Garth, Mounce, Luke TA, Price, Sarah, Rous, Brian, Crosbie, Emma J, Hamilton, Willie, Walter, Fiona M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074643/ https://www.ncbi.nlm.nih.gov/pubmed/33875416 http://dx.doi.org/10.3399/BJGP.2020.0859 |
Ejemplares similares
-
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study
por: Funston, Garth, et al.
Publicado: (2020) -
The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
por: Barr, Chloe E., et al.
Publicado: (2022) -
Detecting ovarian cancer in primary care: can we do better?
por: Funston, Garth, et al.
Publicado: (2022) -
Could Ovarian Cancer Prediction Models Improve the Triage of Symptomatic Women in Primary Care? A Modelling Study Using Routinely Collected Data
por: Funston, Garth, et al.
Publicado: (2021) -
Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
por: Barr, Chloe E., et al.
Publicado: (2021)